CTLA-4 is structurally similar to CD28 and binds to CD80 (B7-1) / CD86 (B7-2) on APCs (or tumor cells) at a higher affinity than CD28, which suggests an interference with T cell activation [14]. Here, CD80 is linked to neoplasm.